Clin Mol Hepatol.  2016 Dec;22(4):439-442. 10.3350/cmh.2016.0108.

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Affiliations
  • 1Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea. drsong8177@naver.com

Abstract

No abstract available.

Keyword

Chronic hepatitis B; Adefovir; Tenofovir; Lamivudine resistance; Suboptimal response
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr